A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Elizabeth I. Buchbinder, Anasuya Gunturi, Jessica Perritt, Janice Dutcher, Sandra Aung, Howard L. Kaufman, Marc S. Ernstoff, Girald P. Miletello, Brendan D. Curti, Gregory A. Daniels, Sapna P. Patel, John M. Kirkwood, Sigrun Hallmeyer, Joseph I. Clark, Rene Gonzalez, John M. Richart, Joe Lutzky, Michael A. Morse, Ryan J. Sullivan, David F. McDermott

ABSTRACT

BACKGROUND: High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However, not all patients respond to immune checkpoint blockade and subsequent therapeutic options need to be explored. METHODS: The PROCLAIM database was queried for patients with metastatic melanoma who had received HD IL-2 after treatment with ipilimumab or without prior ICB. Patient characteristics, toxicity and efficacy were analyzed. RESULTS: A total of 52 metastatic melanoma patients were treated with high dose IL-2 after ipilimumab and 276 patients were treated with high dose IL-2 without prior ICB. The overall response rate in the prior ipilimumab group was 21 % as compared to 12 % in the group that had not received prior ipilimumab. The median overall survival, measured from the initiation of HD IL-2 therapy, was 19.3 months in the prior ipilimumab group and 19.4 months in the no prior ICB group. Toxicities observed on HD IL-2 were relatively equivalent between the groups although there were cases of CTLA4 antibody-induced colitis reported after HD IL-2 treatment and a CTLA4 antibody-induced colitis related death. CONCLUSION: In this retrospective analysis HD IL-2 therapy displayed antitumor activity in melanoma patients who progressed following treatment with ipilimumab. Most HD IL-2 toxicity was not worsened by prior ipilimumab therapy except for one treatment related death from colitis. Care should be taken to avoid reactivation of CTLA4 antibody-induced colitis. More... »

PAGES

52

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8

DOI

http://dx.doi.org/10.1186/s40425-016-0155-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053272676

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27660706


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Dana Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buchbinder", 
        "givenName": "Elizabeth I.", 
        "id": "sg:person.01054005663.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054005663.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lowell General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.461527.3", 
          "name": [
            "The Cancer Center \u2013 Lowell General Hospital, 01854, Lowell, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gunturi", 
        "givenName": "Anasuya", 
        "id": "sg:person.01217161672.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217161672.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Prometheus Labs, 9410 Carroll Park Drive, 92121, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perritt", 
        "givenName": "Jessica", 
        "id": "sg:person.011011237055.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011011237055.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cancer Research Foundation of New York, Chappaqua, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dutcher", 
        "givenName": "Janice", 
        "id": "sg:person.0760406720.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760406720.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Prometheus Labs, 9410 Carroll Park Drive, 92121, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aung", 
        "givenName": "Sandra", 
        "id": "sg:person.01021446352.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021446352.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Rutgers University", 
          "id": "https://www.grid.ac/institutes/grid.430387.b", 
          "name": [
            "Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaufman", 
        "givenName": "Howard L.", 
        "id": "sg:person.01333264012.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333264012.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cleveland Clinic", 
          "id": "https://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Cleveland Clinic, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ernstoff", 
        "givenName": "Marc S.", 
        "id": "sg:person.01115160302.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115160302.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology\\Oncology Clinic", 
          "id": "https://www.grid.ac/institutes/grid.490187.3", 
          "name": [
            "Hematology/Oncology clinic, Baton Rouge, LA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miletello", 
        "givenName": "Girald P.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Providence Health & Services", 
          "id": "https://www.grid.ac/institutes/grid.415286.c", 
          "name": [
            "Providence Health & Services, Portland, OR, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Curti", 
        "givenName": "Brendan D.", 
        "id": "sg:person.01155143760.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155143760.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, San Diego", 
          "id": "https://www.grid.ac/institutes/grid.266100.3", 
          "name": [
            "Moores UCSD Cancer Center, La Jolla, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daniels", 
        "givenName": "Gregory A.", 
        "id": "sg:person.01204312116.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204312116.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Sapna P.", 
        "id": "sg:person.014634030547.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pittsburgh", 
          "id": "https://www.grid.ac/institutes/grid.21925.3d", 
          "name": [
            "University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirkwood", 
        "givenName": "John M.", 
        "id": "sg:person.01274445211.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274445211.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncology Specialists", 
          "id": "https://www.grid.ac/institutes/grid.477670.5", 
          "name": [
            "Oncology Specialists, SC, Park Ridge, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hallmeyer", 
        "givenName": "Sigrun", 
        "id": "sg:person.01201372106.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201372106.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Loyola Medicine", 
          "id": "https://www.grid.ac/institutes/grid.470420.5", 
          "name": [
            "Loyola Medicine, Maywood, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clark", 
        "givenName": "Joseph I.", 
        "id": "sg:person.0767326173.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767326173.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Colorado Anschutz Medical Campus", 
          "id": "https://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "University of Colorado, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonzalez", 
        "givenName": "Rene", 
        "id": "sg:person.016205604122.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016205604122.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saint Louis University", 
          "id": "https://www.grid.ac/institutes/grid.262962.b", 
          "name": [
            "Saint Louis University, 63110, Saint Louis, MO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Richart", 
        "givenName": "John M.", 
        "id": "sg:person.01152205304.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152205304.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.410396.9", 
          "name": [
            "Mount Sinai Medical Center, Miami Beach, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lutzky", 
        "givenName": "Joe", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Duke, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morse", 
        "givenName": "Michael A.", 
        "id": "sg:person.013700705377.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Massachusetts General Hospital, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sullivan", 
        "givenName": "Ryan J.", 
        "id": "sg:person.0743410042.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743410042.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Beth Israel Deaconess Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.239395.7", 
          "name": [
            "Beth Israel Deaconess Medical Center, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McDermott", 
        "givenName": "David F.", 
        "id": "sg:person.0656541200.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1479-5876-9-204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002969174", 
          "https://doi.org/10.1186/1479-5876-9-204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1414428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007696832"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-011-1172-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009295521", 
          "https://doi.org/10.1007/s00262-011-1172-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clindermatol.2012.08.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009310597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(14)60958-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012632588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015678740"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1406498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020435459"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1504030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024843336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2005.03.536", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024972195", 
          "https://doi.org/10.1245/aso.2005.03.536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2005.03.536", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024972195", 
          "https://doi.org/10.1245/aso.2005.03.536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000211334.06762.89", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044142325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000211334.06762.89", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044142325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.53.0105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047895673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1003466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052212829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.7.2105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549817"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However, not all patients respond to immune checkpoint blockade and subsequent therapeutic options need to be explored.\nMETHODS: The PROCLAIM database was queried for patients with metastatic melanoma who had received HD IL-2 after treatment with ipilimumab or without prior ICB. Patient characteristics, toxicity and efficacy were analyzed.\nRESULTS: A total of 52 metastatic melanoma patients were treated with high dose IL-2 after ipilimumab and 276 patients were treated with high dose IL-2 without prior ICB. The overall response rate in the prior ipilimumab group was 21\u00a0% as compared to 12\u00a0% in the group that had not received prior ipilimumab. The median overall survival, measured from the initiation of HD IL-2 therapy, was 19.3\u00a0months in the prior ipilimumab group and 19.4\u00a0months in the no prior ICB group. Toxicities observed on HD IL-2 were relatively equivalent between the groups although there were cases of CTLA4 antibody-induced colitis reported after HD IL-2 treatment and a CTLA4 antibody-induced colitis related death.\nCONCLUSION: In this retrospective analysis HD IL-2 therapy displayed antitumor activity in melanoma patients who progressed following treatment with ipilimumab. Most HD IL-2 toxicity was not worsened by prior ipilimumab therapy except for one treatment related death from colitis. Care should be taken to avoid reactivation of CTLA4 antibody-induced colitis.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40425-016-0155-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2440219", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1049249", 
        "issn": [
          "2051-1426"
        ], 
        "name": "Journal for ImmunoTherapy of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "name": "A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma", 
    "pagination": "52", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "fdbfdd89b0bbe9299b656823af91dfcfe1e7c3a73f89a59a1856fc796b4f8539"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27660706"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101620585"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40425-016-0155-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053272676"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40425-016-0155-8", 
      "https://app.dimensions.ai/details/publication/pub.1053272676"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70046_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs40425-016-0155-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      21 PREDICATES      42 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40425-016-0155-8 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N687fc9e067ca4696ae3a3eae970b9d5e
4 schema:citation sg:pub.10.1007/s00262-011-1172-6
5 sg:pub.10.1186/1479-5876-9-204
6 sg:pub.10.1245/aso.2005.03.536
7 https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m
8 https://doi.org/10.1016/j.clindermatol.2012.08.006
9 https://doi.org/10.1016/s0140-6736(14)60958-2
10 https://doi.org/10.1056/nejmoa1003466
11 https://doi.org/10.1056/nejmoa1406498
12 https://doi.org/10.1056/nejmoa1414428
13 https://doi.org/10.1056/nejmoa1504030
14 https://doi.org/10.1097/01.cji.0000211334.06762.89
15 https://doi.org/10.1200/jco.1999.17.7.2105
16 https://doi.org/10.1200/jco.2013.53.0105
17 schema:datePublished 2016-12
18 schema:datePublishedReg 2016-12-01
19 schema:description BACKGROUND: High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However, not all patients respond to immune checkpoint blockade and subsequent therapeutic options need to be explored. METHODS: The PROCLAIM database was queried for patients with metastatic melanoma who had received HD IL-2 after treatment with ipilimumab or without prior ICB. Patient characteristics, toxicity and efficacy were analyzed. RESULTS: A total of 52 metastatic melanoma patients were treated with high dose IL-2 after ipilimumab and 276 patients were treated with high dose IL-2 without prior ICB. The overall response rate in the prior ipilimumab group was 21 % as compared to 12 % in the group that had not received prior ipilimumab. The median overall survival, measured from the initiation of HD IL-2 therapy, was 19.3 months in the prior ipilimumab group and 19.4 months in the no prior ICB group. Toxicities observed on HD IL-2 were relatively equivalent between the groups although there were cases of CTLA4 antibody-induced colitis reported after HD IL-2 treatment and a CTLA4 antibody-induced colitis related death. CONCLUSION: In this retrospective analysis HD IL-2 therapy displayed antitumor activity in melanoma patients who progressed following treatment with ipilimumab. Most HD IL-2 toxicity was not worsened by prior ipilimumab therapy except for one treatment related death from colitis. Care should be taken to avoid reactivation of CTLA4 antibody-induced colitis.
20 schema:genre research_article
21 schema:inLanguage en
22 schema:isAccessibleForFree true
23 schema:isPartOf Na5b4f4168e134557b89c410213bb8c92
24 Naf53c6991cc44d6e8effba34e2ae5d5a
25 sg:journal.1049249
26 schema:name A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
27 schema:pagination 52
28 schema:productId N3fb4af0d10444da898e557cb3842ce2c
29 N6aa55035384d48218889e66db1ef423c
30 N8b5b82fdb2a04e38b51a653792bc02b9
31 Nb10fbe5dd2c7428d9c119b9a836f3e6c
32 Nebacfeeddaac40a4a85faa10d9b58c25
33 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053272676
34 https://doi.org/10.1186/s40425-016-0155-8
35 schema:sdDatePublished 2019-04-11T12:39
36 schema:sdLicense https://scigraph.springernature.com/explorer/license/
37 schema:sdPublisher Nb6a5a5c268f04abd8d59741cb60fb0eb
38 schema:url https://link.springer.com/10.1186%2Fs40425-016-0155-8
39 sgo:license sg:explorer/license/
40 sgo:sdDataset articles
41 rdf:type schema:ScholarlyArticle
42 N05b24be838584568b88f670e40829ffe rdf:first sg:person.01274445211.76
43 rdf:rest N185d3e75f42d408fb6130385aa1c9ec7
44 N110f13564d1d42eda5cd5f87e126f659 rdf:first sg:person.01333264012.85
45 rdf:rest N243be57f79da4e1bb2c25aa9342516ab
46 N14fce0e395e94617bf26cf506d0bd430 rdf:first sg:person.01021446352.21
47 rdf:rest N110f13564d1d42eda5cd5f87e126f659
48 N185d3e75f42d408fb6130385aa1c9ec7 rdf:first sg:person.01201372106.08
49 rdf:rest N3b2fbd8f09d6446e9ff0b919fe3454de
50 N201b60d5328e4735847897fba8cc5613 rdf:first sg:person.01204312116.53
51 rdf:rest Nd1553806ae304d0eb3457b4e02b60ea5
52 N2308f3f18fa6481a814f982a6d018088 schema:name Prometheus Labs, 9410 Carroll Park Drive, 92121, San Diego, CA, USA
53 rdf:type schema:Organization
54 N243be57f79da4e1bb2c25aa9342516ab rdf:first sg:person.01115160302.45
55 rdf:rest N4fab5d31081d4927bd6f840129bca29d
56 N3315e15d74d1406f84df03d941ec6ec6 schema:name Duke, Durham, NC, USA
57 rdf:type schema:Organization
58 N339daa195b6b449ebf6ad2f31ad70d3c schema:name Cancer Research Foundation of New York, Chappaqua, NY, USA
59 rdf:type schema:Organization
60 N3b2fbd8f09d6446e9ff0b919fe3454de rdf:first sg:person.0767326173.93
61 rdf:rest Nafdc0de9b3dc4d3bb16378d9ed54eeec
62 N3fb4af0d10444da898e557cb3842ce2c schema:name readcube_id
63 schema:value fdbfdd89b0bbe9299b656823af91dfcfe1e7c3a73f89a59a1856fc796b4f8539
64 rdf:type schema:PropertyValue
65 N4fab5d31081d4927bd6f840129bca29d rdf:first N72ee96c1ad4040e987ed3af2888a3a59
66 rdf:rest Nfd647760aafc4c90ad63e3f0733a2fbd
67 N61f2ac6ab606495f82b106669487c48e schema:name Prometheus Labs, 9410 Carroll Park Drive, 92121, San Diego, CA, USA
68 rdf:type schema:Organization
69 N687fc9e067ca4696ae3a3eae970b9d5e rdf:first sg:person.01054005663.52
70 rdf:rest Ne5303f119a4b40478c70468a54570263
71 N6aa55035384d48218889e66db1ef423c schema:name nlm_unique_id
72 schema:value 101620585
73 rdf:type schema:PropertyValue
74 N6c177669707d4a12950ec5cf430048cd rdf:first sg:person.011011237055.94
75 rdf:rest N76f9ebd4279e46119e429a0569dc6ca4
76 N72ee96c1ad4040e987ed3af2888a3a59 schema:affiliation https://www.grid.ac/institutes/grid.490187.3
77 schema:familyName Miletello
78 schema:givenName Girald P.
79 rdf:type schema:Person
80 N76f9ebd4279e46119e429a0569dc6ca4 rdf:first sg:person.0760406720.36
81 rdf:rest N14fce0e395e94617bf26cf506d0bd430
82 N837a38ee9bfe49558e2a1580f1be3324 rdf:first sg:person.013700705377.06
83 rdf:rest Nff04b40dff264c1caf64792db849d3a7
84 N8b5b82fdb2a04e38b51a653792bc02b9 schema:name dimensions_id
85 schema:value pub.1053272676
86 rdf:type schema:PropertyValue
87 N8c8b7c29c0514a80af24b151952a11af rdf:first sg:person.0656541200.82
88 rdf:rest rdf:nil
89 Na034b5ee5b3d4a2aa801c3b673e1f4ad rdf:first sg:person.01152205304.09
90 rdf:rest Ne662076ab34747e1a811be33f6307432
91 Na5b4f4168e134557b89c410213bb8c92 schema:volumeNumber 4
92 rdf:type schema:PublicationVolume
93 Naf53c6991cc44d6e8effba34e2ae5d5a schema:issueNumber 1
94 rdf:type schema:PublicationIssue
95 Nafdc0de9b3dc4d3bb16378d9ed54eeec rdf:first sg:person.016205604122.71
96 rdf:rest Na034b5ee5b3d4a2aa801c3b673e1f4ad
97 Nb10fbe5dd2c7428d9c119b9a836f3e6c schema:name pubmed_id
98 schema:value 27660706
99 rdf:type schema:PropertyValue
100 Nb6a5a5c268f04abd8d59741cb60fb0eb schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 Nb93487b665f74848ba6ebdb7d2c5f725 schema:affiliation https://www.grid.ac/institutes/grid.410396.9
103 schema:familyName Lutzky
104 schema:givenName Joe
105 rdf:type schema:Person
106 Nd1553806ae304d0eb3457b4e02b60ea5 rdf:first sg:person.014634030547.08
107 rdf:rest N05b24be838584568b88f670e40829ffe
108 Ne5303f119a4b40478c70468a54570263 rdf:first sg:person.01217161672.84
109 rdf:rest N6c177669707d4a12950ec5cf430048cd
110 Ne662076ab34747e1a811be33f6307432 rdf:first Nb93487b665f74848ba6ebdb7d2c5f725
111 rdf:rest N837a38ee9bfe49558e2a1580f1be3324
112 Nebacfeeddaac40a4a85faa10d9b58c25 schema:name doi
113 schema:value 10.1186/s40425-016-0155-8
114 rdf:type schema:PropertyValue
115 Nfd647760aafc4c90ad63e3f0733a2fbd rdf:first sg:person.01155143760.43
116 rdf:rest N201b60d5328e4735847897fba8cc5613
117 Nff04b40dff264c1caf64792db849d3a7 rdf:first sg:person.0743410042.57
118 rdf:rest N8c8b7c29c0514a80af24b151952a11af
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
123 schema:name Oncology and Carcinogenesis
124 rdf:type schema:DefinedTerm
125 sg:grant.2440219 http://pending.schema.org/fundedItem sg:pub.10.1186/s40425-016-0155-8
126 rdf:type schema:MonetaryGrant
127 sg:journal.1049249 schema:issn 2051-1426
128 schema:name Journal for ImmunoTherapy of Cancer
129 rdf:type schema:Periodical
130 sg:person.01021446352.21 schema:affiliation N2308f3f18fa6481a814f982a6d018088
131 schema:familyName Aung
132 schema:givenName Sandra
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021446352.21
134 rdf:type schema:Person
135 sg:person.01054005663.52 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
136 schema:familyName Buchbinder
137 schema:givenName Elizabeth I.
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054005663.52
139 rdf:type schema:Person
140 sg:person.011011237055.94 schema:affiliation N61f2ac6ab606495f82b106669487c48e
141 schema:familyName Perritt
142 schema:givenName Jessica
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011011237055.94
144 rdf:type schema:Person
145 sg:person.01115160302.45 schema:affiliation https://www.grid.ac/institutes/grid.239578.2
146 schema:familyName Ernstoff
147 schema:givenName Marc S.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115160302.45
149 rdf:type schema:Person
150 sg:person.01152205304.09 schema:affiliation https://www.grid.ac/institutes/grid.262962.b
151 schema:familyName Richart
152 schema:givenName John M.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152205304.09
154 rdf:type schema:Person
155 sg:person.01155143760.43 schema:affiliation https://www.grid.ac/institutes/grid.415286.c
156 schema:familyName Curti
157 schema:givenName Brendan D.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155143760.43
159 rdf:type schema:Person
160 sg:person.01201372106.08 schema:affiliation https://www.grid.ac/institutes/grid.477670.5
161 schema:familyName Hallmeyer
162 schema:givenName Sigrun
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201372106.08
164 rdf:type schema:Person
165 sg:person.01204312116.53 schema:affiliation https://www.grid.ac/institutes/grid.266100.3
166 schema:familyName Daniels
167 schema:givenName Gregory A.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204312116.53
169 rdf:type schema:Person
170 sg:person.01217161672.84 schema:affiliation https://www.grid.ac/institutes/grid.461527.3
171 schema:familyName Gunturi
172 schema:givenName Anasuya
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217161672.84
174 rdf:type schema:Person
175 sg:person.01274445211.76 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
176 schema:familyName Kirkwood
177 schema:givenName John M.
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274445211.76
179 rdf:type schema:Person
180 sg:person.01333264012.85 schema:affiliation https://www.grid.ac/institutes/grid.430387.b
181 schema:familyName Kaufman
182 schema:givenName Howard L.
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333264012.85
184 rdf:type schema:Person
185 sg:person.013700705377.06 schema:affiliation N3315e15d74d1406f84df03d941ec6ec6
186 schema:familyName Morse
187 schema:givenName Michael A.
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06
189 rdf:type schema:Person
190 sg:person.014634030547.08 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
191 schema:familyName Patel
192 schema:givenName Sapna P.
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08
194 rdf:type schema:Person
195 sg:person.016205604122.71 schema:affiliation https://www.grid.ac/institutes/grid.430503.1
196 schema:familyName Gonzalez
197 schema:givenName Rene
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016205604122.71
199 rdf:type schema:Person
200 sg:person.0656541200.82 schema:affiliation https://www.grid.ac/institutes/grid.239395.7
201 schema:familyName McDermott
202 schema:givenName David F.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82
204 rdf:type schema:Person
205 sg:person.0743410042.57 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
206 schema:familyName Sullivan
207 schema:givenName Ryan J.
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743410042.57
209 rdf:type schema:Person
210 sg:person.0760406720.36 schema:affiliation N339daa195b6b449ebf6ad2f31ad70d3c
211 schema:familyName Dutcher
212 schema:givenName Janice
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760406720.36
214 rdf:type schema:Person
215 sg:person.0767326173.93 schema:affiliation https://www.grid.ac/institutes/grid.470420.5
216 schema:familyName Clark
217 schema:givenName Joseph I.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767326173.93
219 rdf:type schema:Person
220 sg:pub.10.1007/s00262-011-1172-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009295521
221 https://doi.org/10.1007/s00262-011-1172-6
222 rdf:type schema:CreativeWork
223 sg:pub.10.1186/1479-5876-9-204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002969174
224 https://doi.org/10.1186/1479-5876-9-204
225 rdf:type schema:CreativeWork
226 sg:pub.10.1245/aso.2005.03.536 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024972195
227 https://doi.org/10.1245/aso.2005.03.536
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1015678740
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.clindermatol.2012.08.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009310597
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/s0140-6736(14)60958-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012632588
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1056/nejmoa1003466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052212829
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1056/nejmoa1406498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020435459
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1056/nejmoa1414428 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007696832
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1056/nejmoa1504030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024843336
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1097/01.cji.0000211334.06762.89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044142325
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1200/jco.1999.17.7.2105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549817
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1200/jco.2013.53.0105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047895673
248 rdf:type schema:CreativeWork
249 https://www.grid.ac/institutes/grid.21925.3d schema:alternateName University of Pittsburgh
250 schema:name University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
251 rdf:type schema:Organization
252 https://www.grid.ac/institutes/grid.239395.7 schema:alternateName Beth Israel Deaconess Medical Center
253 schema:name Beth Israel Deaconess Medical Center, Boston, MA, USA
254 rdf:type schema:Organization
255 https://www.grid.ac/institutes/grid.239578.2 schema:alternateName Cleveland Clinic
256 schema:name Cleveland Clinic, Cleveland, OH, USA
257 rdf:type schema:Organization
258 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
259 schema:name The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA
260 rdf:type schema:Organization
261 https://www.grid.ac/institutes/grid.262962.b schema:alternateName Saint Louis University
262 schema:name Saint Louis University, 63110, Saint Louis, MO, USA
263 rdf:type schema:Organization
264 https://www.grid.ac/institutes/grid.266100.3 schema:alternateName University of California, San Diego
265 schema:name Moores UCSD Cancer Center, La Jolla, CA, USA
266 rdf:type schema:Organization
267 https://www.grid.ac/institutes/grid.32224.35 schema:alternateName Massachusetts General Hospital
268 schema:name Massachusetts General Hospital, Boston, MA, USA
269 rdf:type schema:Organization
270 https://www.grid.ac/institutes/grid.410396.9 schema:alternateName Mount Sinai Medical Center
271 schema:name Mount Sinai Medical Center, Miami Beach, FL, USA
272 rdf:type schema:Organization
273 https://www.grid.ac/institutes/grid.415286.c schema:alternateName Providence Health & Services
274 schema:name Providence Health & Services, Portland, OR, USA
275 rdf:type schema:Organization
276 https://www.grid.ac/institutes/grid.430387.b schema:alternateName Rutgers University
277 schema:name Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
278 rdf:type schema:Organization
279 https://www.grid.ac/institutes/grid.430503.1 schema:alternateName University of Colorado Anschutz Medical Campus
280 schema:name University of Colorado, Aurora, CO, USA
281 rdf:type schema:Organization
282 https://www.grid.ac/institutes/grid.461527.3 schema:alternateName Lowell General Hospital
283 schema:name The Cancer Center – Lowell General Hospital, 01854, Lowell, MA, USA
284 rdf:type schema:Organization
285 https://www.grid.ac/institutes/grid.470420.5 schema:alternateName Loyola Medicine
286 schema:name Loyola Medicine, Maywood, IL, USA
287 rdf:type schema:Organization
288 https://www.grid.ac/institutes/grid.477670.5 schema:alternateName Oncology Specialists
289 schema:name Oncology Specialists, SC, Park Ridge, IL, USA
290 rdf:type schema:Organization
291 https://www.grid.ac/institutes/grid.490187.3 schema:alternateName Hematology\Oncology Clinic
292 schema:name Hematology/Oncology clinic, Baton Rouge, LA, USA
293 rdf:type schema:Organization
294 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
295 schema:name Dana Farber Cancer Institute, Boston, MA, USA
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...